A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma.

MLA

Chia, W. K., et al. “A Phase II Study Evaluating the Safety and Efficacy of an Adenovirus-ΔLMP1-LMP2 Transduced Dendritic Cell Vaccine in Patients with Advanced Metastatic Nasopharyngeal Carcinoma.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 23, no. 4, Apr. 2012, pp. 997–1005. EBSCOhost, https://doi.org/10.1093/annonc/mdr341.

APA

Chia, W. K., Wang, W.-W., Teo, M., Tai, W. M., Lim, W. T., Tan, E. H., Leong, S. S., Sun, L., Chen, J. J., Gottschalk, S., & Toh, H. C. (2012). A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 23(4), 997–1005. https://doi.org/10.1093/annonc/mdr341

Chicago

Chia, W K, W-W Wang, M Teo, W M Tai, W T Lim, E H Tan, S S Leong, et al. 2012. “A Phase II Study Evaluating the Safety and Efficacy of an Adenovirus-ΔLMP1-LMP2 Transduced Dendritic Cell Vaccine in Patients with Advanced Metastatic Nasopharyngeal Carcinoma.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 23 (4): 997–1005. doi:10.1093/annonc/mdr341.